MBX
MBX Biosciences·NASDAQ
--
--(--)
--
--(--)
5.39 / 10
Netural
Analyst sentiment is bullish with Guggenheim and Barclays maintaining Buy/Strong Buy ratings, and a sentiment score of 5.39/10. Fund-flow analysis shows a good overall score (7.39/10), with small and large orders leaning positive while medium and block flows are mixed. This blend indicates healthy liquidity and institutional interest, reinforcing the neutral-to-positive consensus.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
50%
Buy
50%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-28
InstitutionBarclays
Times predicted1
Historical Win Rate100.0%
What is the market sentiment for MBX?
- MBX holds a Bearish analyst rating, with 50% of experts assigning a Strong Buy grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 5.39/10 (Netural).
